The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letters to the EditorFull Access

Suicidality and Antidepressants

Published Online:https://doi.org/10.1176/pn.40.10.00400052a

It is important to bring to the attention of clinicians and researchers who are of a younger generation than my own (I practiced for more than 50 years) that suicidality is a risk when very depressed patients begin to improve. I believe that this risk occurs independently of antidepressants per se.

The severely depressed are too apathetic to activate suicide. In my clinical generation, all very depressed patients were placed on suicide watch as they improved. We used to tranquilize patients in the agitated stage, which is a clinical phase. Antidepressants do not “cause” suicide; they merely enable action.

For the last 10 years I was in charge of a large adolescent treatment facility. Many patients who were diagnosed as just depressive and placed on antidepressants were later found to be bipolar.

I believe that antidepressants activated their mania with symptoms of agitated self-destructive attempts and threats. Antidepressants were falsely accused of “causing” the suicidality.

It is best to regard all depressed teenagers as possibly or even likely bipolar and monitor them very closely. Parents should be warned to watch for signs of activation or excitement.

Sedona, Ariz.